Company: CYTK
Filing Date: 2025-02-11
Form Type: 8-K
Source: 0000950170-25-017458
Chunk: 1

Company: CYTOKINETICS INC
Filing Date: 2025-02-11
Form: 8-K
Item: Item 5.02
Chunk 1
---
 the Effective Date, Mr. Landry received an option to purchase 25,538 shares of the Company’s common stock (the “Initial Grant”), which represent stock options with a grant date fair value of $700,000. The Initial Grant will vest monthly over the period commencing on the Effective Date and ending on the three-year anniversary of the Effective Date, subject to his continuous service as a member of the Board. The Company also entered into its standard form of indemnification agreement with Mr. Landry.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                             CYTOKINETICS, INCORPORATED  
  Date:      February 11, 2025      By:      /s/ John O. Faurescu        
                                             John O. Faurescu, Esq.